Interleukin-1 beta inhibition with canakinumab and reducing lung cancer-subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)-MedSci.cn

Interleukin-1 beta inhibition with canakinumab and reducing lung cancer-subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)

Crossman, D; Rothman, AMK

Crossman, D (reprint author), Univ St Andrews, Sch Med, St Andrews, Fife, Scotland.

JOURNAL OF THORACIC DISEASE, 2018; 10 (): S3084

科室
- - 订阅+
  - 更多科室
工具
服务